Literature DB >> 8108373

Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study.

S T Chari1, V Mohan, C S Pitchumoni, M Viswanathan, N Madanagopalan, A B Lowenfels.   

Abstract

To assess the risk of pancreatic cancer in subjects with tropical calcifying pancreatitis (TCP), we have followed 185 patients with TCP from the Diabetes Research Center in Madras, India for an average of 4.5 years. The diagnosis of TCP was based upon long-standing epigastric pain, laboratory tests, presence of pancreatic calculi, endoscopic retrograde cholangiopancreatography (ERCP) findings, and ultrasonography. During the follow-up period, 24 patients died from all causes, with 6 deaths (25%) from cancer of the pancreas. Three pancreatic cancers were biopsy positive. Average age at onset of pancreatic cancer was 45.6 +/- 7.3 years--considerably younger than for Western populations. When compared with the background pancreatic cancer rate, subjects with TCP appear to have a significantly increased risk of pancreatic cancer: relative risk = 100, 95% CI = 37-218. Even under the most stringent assumptions (restricting the analysis to biopsy-proven cases, assuming that the true background rate of pancreatic cancer in Madras resembles high-risk Western populations, assuming that tropical pancreatitis begins at birth) the risk is still elevated: relative risk = 5, 95% CI = 1.03-3-14.6. The exact mechanism linking various forms of pancreatitis to pancreatic cancer remains to be elucidated.

Entities:  

Mesh:

Year:  1994        PMID: 8108373     DOI: 10.1097/00006676-199401000-00009

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  29 in total

Review 1.  The novel triad of dorsal agenesis of the pancreas with concurrent pancreatic ductal adenocarcinoma and nonalcoholic chronic calcific pancreatitis: a case series and review of the literature.

Authors:  David W Rittenhouse; Eugene P Kennedy; Andres A Mascaro; Jennifer L Brumbaugh; Louis H Stein; Laura H Rosenberger; Patricia K Sauter; Charles J Yeo; Harish Lavu
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 2.  Tropical pancreatitis.

Authors:  Rakesh K Tandon
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

3.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

4.  Pancreatic cancer in chronic pancreatitis.

Authors:  Puneet Dhar; S Kalghatgi; Vivek Saraf
Journal:  Indian J Surg Oncol       Date:  2015-01-21

Review 5.  Genetic and phenotypic heterogeneity in tropical calcific pancreatitis.

Authors:  Sumit Paliwal; Seema Bhaskar; Giriraj R Chandak
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 6.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

7.  Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Strzelczyk; Adam Janiak; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 8.  Tropical chronic pancreatitis.

Authors:  K K Barman; G Premalatha; V Mohan
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

Review 9.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

Review 10.  Pancreatic cancer and its stroma: a conspiracy theory.

Authors:  Zhihong Xu; Srinivasa P Pothula; Jeremy S Wilson; Minoti V Apte
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.